Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by jopatcloon Nov 07, 2024 7:30am
80 Views
Post# 36300451

😎 Now 4.0 Europe & Canada. Now FDA 4.0 anytime and sales🚀

😎 Now 4.0 Europe & Canada. Now FDA 4.0 anytime and sales🚀Interesting on Mayo Clinic !
And here we go! It is on.

Mayo Clinic Beahrs Surgical Innovation Summit in Rochester, Mn.

This is by design a highly curated and invite-only event in it’s third year.

Based upon the attendees, content, real world discussions and a one-day absolutely packed agenda, this will continue to emerge as an experience that will provide insights and see around corners in our rapidly emerging tech world of healthcare.

I am privileged to be co-moderating with @Paul Rudolph, three stacked panels:

The Future of Data and AI in Surgery

- Brian Miller
with Intuitive
- David Niewolny
with NVIDIA
- Cornelius Thiels with Mayo Clinic

The Future of Image Guided Therapies in Surgery

- Santiago Horgan
- @Jonathan Morrison with Mayo
- Stephen Boppart
- Philip Rackliffe with GE HealthCare

The Future of Wearables in Surgery

- @Erica Loomis with Mayo
- Peter Fitzgerald with Stanford University School of Medicine

This event is hosted by the Department of Surgery at Mayo and we will have 100 top surgeons with Mayo having critical discussions with the medtech strategics such as Johnson & Johnson, Intuitive, Medtronic, Stryker, GE HealthCare, Siemens Healthineers, BD, Olympus Corporation of the Americas, Boston Scientific, W. L. Gore & Associates.

A big thanks to the amazing leadership provided by Summit Chair – Janani Reisenauer and Committee Chair - Lisa Carmel

<< Previous
Bullboard Posts
Next >>